Clinical trial
Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II
NCT00002921 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II
- Lead sponsor
- SWOG Cancer Research Network
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 1997
- Completion date
- January 31, 2004
- Enrollment
- 13 (actual)
- Sites
- 65
Conditions
As the registry lists them; a condition with its own page is linked.